Foresee Pharmaceuticals , Ltd. Overview
Foresee Pharmaceuticals , Ltd. (6576.TWO) has a ROE of 1.77%, below the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow1.77%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Foresee Pharmaceuticals , Ltd.'s return on equity stands at 1.77%. That is below the sector sector average of 11.64%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Foresee Pharmaceuticals , Ltd. sits lower the its sector benchmark (11.64%) with a ROE of 1.77%. That is roughly 84.8% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A ROE of 1.77% for Foresee Pharmaceuticals , Ltd. means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Foresee Pharmaceuticals , Ltd.'s ROE evolved across reporting periods, while the comparison chart places 6576.TWO next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
